Written questions by Cane.

If his Department will introduce rolling three-year settlements for the health element of children's palliative care.

We are providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. I am pleased to confirm the continuation of circa £26 million, adjusted for inflation, for the next three financial years, 2026/27 to 2028/29 inclusive, to be distributed again via integrated care boards. This amounts to approximately £80 million over the next three years.We are also supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.The Government is developing a Palliative Care and End of Life Care Modern Service Framework for England. I refer the Hon. Member to the Written Ministerial Statement HCWS1087, which I gave to the House on 24 November 2025.

What assessment his Department has made of the potential impact of removing the relevant target from the NHS Operational Planning Guidance 2025-6 on the dementia diagnosis rate.

The Darzi Investigation found that there are too many targets set for the National Health Service, which made it hard for local systems to prioritise their actions or to be held properly accountable.Our aim is to give more power to local systems and let them decide how they use local funding to best meet the needs of their local population.NHS Planning Guidance is not an exhaustive list of everything the NHS does, and the absence of a target does not mean it is not an area of focus. We remain committed to recovering the dementia diagnosis rate to the national ambition of 66.7%.We will deliver the first ever Frailty and Dementia Modern Service Framework to deliver rapid and significant improvements in the quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.The Frailty and Dementia Modern Service Framework will seek to reduce unwarranted variation and narrow inequality for those living with dementia, and will set national standards for dementia care and redirect NHS priorities to provide the best possible care and support.

What assessment his Department has made of the adequacy of dementia care provision in Ely and East Cambridgeshire constituency.

The Government is empowering local leaders with the autonomy they need to provide the best services to their local community, including for those with dementia.That is why we have published the D100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for system leaders and help create communities and services where the best possible care and support is available to those with dementia. The tool is available at the following link:https://www.rcpsych.ac.uk/improving-care/nccmh/service-design-and-development/dementia-100-pathway-assessment-toolWe will also deliver the first ever Frailty and Dementia Modern Service Framework to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.The Frailty and Dementia Modern Service Framework will seek to reduce unwarranted variation and narrow inequality for those living with dementia, and will set national standards for dementia care and redirect National Health Service priorities to provide the best possible care and support.

What steps he is taking to support research into (a) treatments and (b) a cure for postural tachycardia syndrome.

The Department funds health and care research through the National Institute for Health and Care Research (NIHR). The NIHR funds clinical, public health, and social care research and works in partnership with the National Health Service, universities, local government, other research funders, patients, and the public. The NIHR welcomes proposals for research into a range of conditions, including postural tachycardia syndrome, at the following link: https://www.nihr.ac.uk/get-involved/suggest-a-research-topic

Whether his Department is taking steps to ensure that communities have access to local pharmacies.

The Government recognises that pharmacies, including in Ely and East Cambridgeshire, are an integral part of the fabric of our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from the new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and can fund the contract from the ICBs’ budgets. In some rural areas where a pharmacy may not be viable, local general practices are permitted to dispense medicines to their patients. In addition, patients can choose to access medicines through any of the distance selling pharmacies that are required to deliver the medicines they dispense free of charge, and which also provide other pharmaceutical services remotely.

What assessment he has made of the adequacy of pharmacy provision in rural areas.

The Government recognises that pharmacies, including in Ely and East Cambridgeshire, are an integral part of the fabric of our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from the new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and can fund the contract from the ICBs’ budgets. In some rural areas where a pharmacy may not be viable, local general practices are permitted to dispense medicines to their patients. In addition, patients can choose to access medicines through any of the distance selling pharmacies that are required to deliver the medicines they dispense free of charge, and which also provide other pharmaceutical services remotely.

What assessment he has made of disparities between (a) regions and (b) urban and rural areas in the level of mental health among young people.

The Department routinely monitors mental health inequalities through robust population-based prevalence surveys. The National Health Service Mental Health of Children and Young People Survey (MHCYPS) provides critical insights into youth mental health prevalence and associated risk factors. The 2020 survey found significant regional variation in the prevalence of probable mental disorders in children aged between five and 16 in England, ranging from 10.0% in London to 20.5% in the West Midlands. For adults, the 2023/24 Adult Psychiatric Morbidity Survey, which covers people aged 16 and over, also found regional differences in common mental health conditions. People in the North East (24.6%) and East Midlands (24.6%) were more likely to have a common mental health condition than those in the South East (16.3%) and South West (18.7%). Narrowing mental health inequalities is a key commitment in the 10-Year Health Plan. We are piloting neighbourhood mental health centres around the country, in both rural and urban areas, and making it easier than ever before to receive mental health support via the NHS app.

Pursuant to the Answer of 15 September 2025 to Question 74866 on Palliative Care: Children, when he discussed the potential merits of introducing multi-year NHS funding for the health elements of children's palliative care with integrated care boards.

Children and young people’s hospices do incredible work to support seriously ill children and their families and loved ones when they need it most, and we recognise the incredibly tough pressures they are facing.We are providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which, until recently, was known as the Children’s Hospice Grant.I can also now confirm the continuation of this vital funding for the three years of the next spending review period, 2026/27 to 2028/29 inclusive. This funding will see circa £26 million, adjusted for inflation, allocated to children’s and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.This revenue funding is intended to be spent by hospices to provide high-quality care and support for the children and the families they care for, either in the hospice or in the community, including in children's homes. They can, for example, use this funding for providing respite care for children who have high health needs, by providing physiotherapy or occupational therapy, or by providing 24/7 nursing support for a child at the end of their life.We are also supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.

Whether his Department has undertaken research on the potential impact of the the introduction of multi-year NHS funding for the health elements of children's palliative care on (a) fiscal and (b) health outcomes.

Children and young people’s hospices do incredible work to support seriously ill children and their families and loved ones when they need it most, and we recognise the incredibly tough pressures they are facing.We are providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which, until recently, was known as the Children’s Hospice Grant.I can also now confirm the continuation of this vital funding for the three years of the next spending review period, 2026/27 to 2028/29 inclusive. This funding will see circa £26 million, adjusted for inflation, allocated to children’s and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.This revenue funding is intended to be spent by hospices to provide high-quality care and support for the children and the families they care for, either in the hospice or in the community, including in children's homes. They can, for example, use this funding for providing respite care for children who have high health needs, by providing physiotherapy or occupational therapy, or by providing 24/7 nursing support for a child at the end of their life.We are also supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.

What assessment he has made of trends in the level of inequalities in cancer treatment access in Ely and East Cambridgeshire constituency.

The Government is committed to improving outcomes for cancer patients across England, including in Ely and East Cambridgeshire.The Cambridge University Hospitals NHS Foundation Trust has a strong track record in delivering the cancer performance standards over the years. There is a comprehensive action plan to address the recent deterioration in the waiting times that patients are experiencing for cancer diagnostics and treatment. This includes the provision of additional consultant appointments and theatre lists, as well as recruitment to expand capacity across a number of treatment pathways, with breast, urology, and skin cancer services identified as specific priorities to meet local needs.A new Cancer Operational Taskforce has been launched to drive the delivery of the actions required to improve cancer waiting times for patients, including those who reside within the Ely constituency area.The Department will publish a National Cancer Plan which will include further details on how we will improve outcomes for cancer patients across England, speed up diagnosis and treatment, and ensure that patients have access to the latest treatments and technology.Reducing inequalities is also a key priority for the National Cancer Plan. The plan will look at the targeted improvements needed across different cancer types to reduce disparities in cancer survival and will develop interventions to tackle these. This includes looking at protected characteristics, as well as inequalities related to socioeconomic status, ethnicity, and geographic location. We know that people living in deprived areas are less likely to have their cancers diagnosed at an early stage, when treatment can be more effective, and we want to reduce the gap in early diagnosis between those living in the richest and poorest areas through the National Cancer Plan.

What steps he plans to take to improve cancer waiting times in Ely and East Cambridgeshire constituency.

The Government is committed to improving outcomes for cancer patients across England, including in Ely and East Cambridgeshire.The Cambridge University Hospitals NHS Foundation Trust has a strong track record in delivering the cancer performance standards over the years. There is a comprehensive action plan to address the recent deterioration in the waiting times that patients are experiencing for cancer diagnostics and treatment. This includes the provision of additional consultant appointments and theatre lists, as well as recruitment to expand capacity across a number of treatment pathways, with breast, urology, and skin cancer services identified as specific priorities to meet local needs.A new Cancer Operational Taskforce has been launched to drive the delivery of the actions required to improve cancer waiting times for patients, including those who reside within the Ely constituency area.The Department will publish a National Cancer Plan which will include further details on how we will improve outcomes for cancer patients across England, speed up diagnosis and treatment, and ensure that patients have access to the latest treatments and technology.Reducing inequalities is also a key priority for the National Cancer Plan. The plan will look at the targeted improvements needed across different cancer types to reduce disparities in cancer survival and will develop interventions to tackle these. This includes looking at protected characteristics, as well as inequalities related to socioeconomic status, ethnicity, and geographic location. We know that people living in deprived areas are less likely to have their cancers diagnosed at an early stage, when treatment can be more effective, and we want to reduce the gap in early diagnosis between those living in the richest and poorest areas through the National Cancer Plan.

What steps he is taking to increase funding for research and innovation to improve cancer outcomes.

Research is crucial in tackling cancer, which is why the Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). Cancer is one of the largest areas of spend at over £141.6 million in 2024/25, reflecting its high priority.As well as funding cancer research, the Department also invests in centres of excellence, services and facilities to enable and delivery of cancer research in England. This includes NIHR funding for the Experimental Cancer Medicine Centres, a UK-wide network for delivery of early phase cancer trials, and NIHR’s Biomedical Research Centres, collaborations between world-leading universities and NHS organisations, bringing together academics and clinicians to do translational research, including for all cancer types. NIHR also works closely with industry to bring innovative research to the United Kingdom. This creates a strong portfolio of work reflecting the need for research and innovation to improve cancer outcomes.Additionally, the Office for Life Sciences’ Cancer Healthcare Goals Programme have invested £21.5m to date for cancer research and innovation programmes, with their aim to maximise and direct global industrial investment for the development and acceleration of new cancer diagnostic and therapeutic technologies and devices in the UK through: providing research investments to support the development of innovations in the early stages of the development pathway; and supporting industry to accelerate cancer diagnostic and therapeutic technologies and devices in the latter stages of development into the National Health Service.The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology.The NIHR continues to encourage and welcome applications for research into any aspect of human health and care, including all cancer types.

If he will take further steps to support children's hospices with their energy costs.

While most palliative care and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including children’s hospices, also play in providing support to people at the end of life and their loved ones.Most children’s hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding each charitable hospice receives varies both within and between integrated care board (ICB) areas. This will vary depending on demand in that ICB area but will also be dependent on the totality and type of palliative and end of life care provision from both NHS and non-NHS services, including charitable hospices, within each ICB area.We are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care. We know that many hospices have chosen to use this funding on energy efficiency measures, such as boiler upgrades or solar panel installation, to reduce energy costs and improve efficiency in the longer term.We are also providing £26 million of revenue funding to support children and young people’s hospices for 2025/26.

Whether he has considered introducing multi-year NHS funding for the health elements of children's palliative care.

Palliative care services, including for children, are included in the list of services that integrated care boards (ICBs) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. ICBs are responsible for the commissioning of palliative and end of life care services, to meet the needs of their local populations. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.The Department and NHS England are looking at how to improve the access, quality and sustainability of all-age palliative care and end of life care in line with the 10 Year Health Plan. The Government and the National Health Service will closely monitor the shift towards strategic commissioning of palliative care and end of life care services to ensure that the future state of services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.

When he will respond to Question 59924 on aplastic anaemia tabled on 13 June 2025.

I refer the hon. Member to the answer I gave on 10 July 2025 to Question 59924.

What steps he is taking to ensure that integrated care boards (a) commission children’s palliative care and (b) fund children’s hospices in (i) an equitable and (ii) a sustainable way.

Palliative care services, including children’s palliative care services, are included in the list of services an integrated care board (ICB) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and a service specification for children and young people. ICBs are responsible for the commissioning of palliative and end of life care services to meet the needs of their local populations. Whilst the majority of palliative care and end of life care is provided by National Health Service staff and services, we recognise the important contribution that children and young people’s hospices make to care and support for babies, children, and young people with life-threatening and life-limiting conditions, as well as to their families. NHS England has provided £26 million in revenue funding for children and young people’s hospices for 2025/26, through what was, until recently, known as the Children and Young People’s Hospice Grant. This was an increase in funding from £25 million in 2024/25.ICBs will once again administer the funding to their respective children and young people’s hospices on behalf of NHS England. The majority of children and young people’s hospices should now have received their allocations, with the remaining few receiving theirs in the coming weeks.In February 2025, I met with key palliative care and end of life care and hospice stakeholders, including Together for Short Lives, in a roundtable format with a focus on long-term sector sustainability within the context of our 10-Year Health Plan.

If he will make it his policy to (a) continue to provide financial support for children's hospices and (b) increase the level of funding in line with (i) inflation and (ii) rises in costs.

NHS England has provided £26 million in revenue funding for children and young people’s hospices for 2025/26, through what was, until recently, known as the Children and Young People’s Hospice Grant. This was an increase in funding from £25 million in 2024/25.Integrated care boards will once again administer the funding to their respective children and young people’s hospices on behalf of NHS England. The majority of children and young people’s hospices should now have received their allocations, with the remaining few receiving theirs in the coming weeks.We cannot yet confirm what the funding for 2026/27 will be, or how it will be administered.In February, I met with key palliative care and end of life care and hospice stakeholders, including Together for Short Lives, in a roundtable format with a focus on long-term sector sustainability within the context of our 10-Year Health Plan.

If he will take steps to ensure that aplastic anaemia is (a) recognised and (b) included on the NHS England website; and if he will make an assessment of the potential merits of providing accessible information on this condition for (i) patients and (ii) healthcare professionals.

Working under the UK Rare Diseases Framework, the Government is committed to improving the lives of those living with rare diseases, such as aplastic anaemia.There are over 7,000 rare diseases often needing highly specialised input, and so the National Health Service website is not always the most appropriate platform to disseminate such information. We receive many requests for new topics, including aplastic anaemia, and each one is assessed and prioritised according to a set of criteria. The factors considered when making these decisions include demand for the topic, how well it aligns to achieving strategic priorities, whether it will provide a cost saving for the NHS, suitability for a national audience, prevalence of the condition/symptom and whether other healthcare information providers are better placed to host the information than us, for example, charities. At this stage there are no plans to add aplastic anaemia to the NHS website.However, we continue to add further information on rare diseases to the resources provided by the NHS Genomics Education Programme (GEP). These resources are designed for all healthcare professionals and include information on rare diseases for non-specialists through ‘bitesize’ genomics content. The GEP has a ‘just in time’ resource called ‘GeNotes’ and has developed a two-week Massive Open Online Course to support clinicians in a general approach to rare disease. NHS England has an established patient advisory group for genomics education to ensure lived experience and patient voices are an integral part of the GEP resources and to determine the direction of travel for the programme aligned to their priorities. Additionally, work continues in partnership with Medics For Rare Disease to expand the programme’s remit into non-genetic rare disease.

Whether he has made an assessment of the potential merits of prescribing Mounjaro for Cushing's syndrome on the NHS.

The Department has made no assessment. Mounjaro is not licensed as a treatment option for Cushing’s syndrome. The National Institute for Health and Care Excellence (NICE) would consider an evaluation of Mounjaro for Cushing’s syndrome if the company, Eli Lilly, were to apply to the Medicines and Healthcare products Regulatory Agency for a marketing authorisation, or licence, for use in the treatment of Cushing’s syndrome.Clinicians can prescribe medicines outside of their licensed indication, known as “off-label” use, where there is sufficient evidence and/or experience of using the medicine to show its safety, quality, and efficacy, provided there is no suitable alternative licensed medicine, and subject to funding by the National Health Service locally.

What steps his Department plans to take to improve access to mental health services.

People with mental health issues are not getting the support or care they need, which is why we will fix the broken system to ensure we give mental health the same attention and focus as physical health, so that people can be confident in accessing high quality mental health support when they need it.Nationally, we plan to recruit an additional 8,500 mental health workers across child and adult mental health services in England to reduce delays and provide faster treatment. We will also provide access to a specialist mental health professional in every school and roll out Young Futures hubs in every community.